A student-run venture capital fund at UC San Diego has participated in a $16 million Series B round of funding in startup Savara Pharmaceuticals Inc.
Students in UCSD’s Rady School of Management invested in the Austin, Texas-based company which develops antibiotics for pulmonary disease.
Other investors include the Tech Coast Angels, an angel investor network with the majority of its affiliates in Southern California, the North Texas Angel Network, the Central Texas Angel Network and the Keiretsu Forum.
“The Rady Venture Fund students are instrumental in the process of identifying and evaluating investment opportunities, such as Savara,” Sergio Gurrieri, investor and business adviser at Tech Coast Angels, said, in a statement. “Their diverse backgrounds contribute a wealth of experience and industry knowledge to ensure investments are technically and fiscally sound.”
— SDBJ Staff Report